Fascin, an actin-bundling protein, promotes breast cancer progression in vitro

Cell Biochemistry and Function

Volumn 29, Issue 4, 2011, Pages 303-310

  Xing, Peng ^a   Li, Ji Guang ^a   Jin, Feng ^a   Zhao, Ting Ting ^a   Liu, Qun ^a   Dong, Hui Ting ^a   Wei, Xiao Lin ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

Breast cancer; Epithelial mesenchymal transition (EMT); Fascin; Invasion; Proliferation

Indexed keywords

CD24 ANTIGEN; CD44V ANTIGEN; FASCIN;

ARTICLE; BREAST CANCER; CANCER CELL; CANCER GROWTH; CELL ADHESION; CELL INVASION; CELL PROLIFERATION; CELL SUBPOPULATION; CONTROLLED STUDY; EPITHELIAL MESENCHYMAL TRANSITION; HUMAN; HUMAN CELL; METASTASIS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; STEM CELL; WESTERN BLOTTING;

ANTIGENS, CD24; ANTIGENS, CD44; BLOTTING, WESTERN; BREAST NEOPLASMS; CARRIER PROTEINS; CELL ADHESION; CELL LINE, TUMOR; CELL PROLIFERATION; DOWN-REGULATION; EPITHELIAL-MESENCHYMAL TRANSITION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE KNOCKDOWN TECHNIQUES; HUMANS; MICROFILAMENT PROTEINS; NEOPLASM INVASIVENESS; RNA, SMALL INTERFERING; TRANSFECTION;

EID: 79958812303     PISSN: 02636484     EISSN: 10990844     Source Type: Journal    
DOI: 10.1002/cbf.1750     Document Type: Article

References (34)

1. Steeg PS, Theodorescu D. Metastasis: a therapeutic target for cancer. Nat Clin Pract Oncol 2008; 5: 206-219.
2. Steeg PS. Tumor metastasis: mechanistic insights and clinical challenges. Nat Med 2006; 12: 895-904.
3. Machesky LM. Lamellipodia and filopodia in metastasis and invasion. FEBS Lett 2008; 582: 2102-2111.
4. Kedrin D, van Rheenen J, Hernandez L, Condeelis J, Seagall J. Cell motility and cytoskeletal regulation in invasion and metastasis. J Mammary Gland Biol Neoplasia 2007; 12: 143-152.
5. Li A, Dawson JC, Forero-Vargas M, et al. The actin-bundling protein fascin stabilizes actin in invadopodia and potentiates protrusive invasion. Curr Biol 2010; 20: 339-345.
6. Adams JC. Roles of fascin in cell adhesion and motility. Curr Opin Cell Biol 2004; 16: 590-596.
7. Grothey A, Hashizume R, Sahin AA, McCrea PD. Fascin, an actin-bundling protein associated with cell motility, is up-regulated in hormone receptor negative breast cancer. Br J Cancer 2000; 83: 870-873.
8. Qualtrough D, Singh K, Banu N, Paraskeva C, Pignatelli M. The actin-bundling protein fascin is overexpressed in colorectal adenomas and promotes motility in adenoma cells in vitro. Br J Cancer 2009; 101: 1124-1129.
9. Goncharuk VN, Ross JS, Carlson JA. Actin-binding protein fascin expression in skin neoplasia. J Cutan Pathol 2002; 29: 430-438.
10. Pelosi G, Pasini F, Fraggetta F, et al. Independent value of fascin immunoreactivity for predicting lymph node metastases in typical and atypical pulmonary carcinoids. Lung Cancer 2003; 42: 203-213.
11. Darnel AD, Behmoaram E, Vollmer RT, et al. Fascin regulates prostate cancer cell invasion and is associated with metastasis and biochemical failure in prostate cancer. Clin Cancer Res 2009; 15: 1376-1383.
12. Hu W, McCrea PD, Deavers M, Kavanagh JJ, Kudelka AP, Verschaegen CF. Increased expression of fascin, motility associated protein, in cell cultures derived from ovarian cancer and in borderline and carcinomatous ovarian tumors. Clin Exp Metastasis 2000; 18: 83-88.
13. Yoder BJ, Tso E, Skacel M, et al. The expression of fascin, an actin-bundling motility protein, correlates with hormone receptor-negative breast cancer and a more aggressive clinical course. Clin Cancer Res 2005; 11: 186-192.
14. Rodríguez-Pinilla SM, Sarrió D, Honrado E, et al. Prognostic significance of basal-like phenotype and fascin expression in node-negative invasive breast carcinomas. Clin Cancer Res 2006; 12: 1533-1539.
15. Grothey A, Hashizume R, Ji H, et al. C-erbB-2/HER-2 upregulates fascin, an actin-bundling protein associated with cell motility, in human breast cancer cell lines. Oncogene 2000; 19: 4864-4875.
16. Al-Hajj M, Wicha MS, Benito-Hernandez A, Morrison SJ, Clarke MF. Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci USA 2003; 100: 3983-3988.
17. Balic M, Lin H, Young L, et al. Most early disseminated cancer cells detected in bone marrow of breast cancer patients have a putative breast cancer stem cell phenotype. Clin Cancer Res 2006; 12: 5615-5621.
18. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem 1951; 193: 265-275.
19. Price JE, Polyzos A, Zhang RD, et al. Tumorigenicity and metastasis of human breast carcinoma cell lines in nude mice. Cancer Res 1990; 50: 717-721.
20. Thiery JP. Epithelial-mesenchymal transitions in tumour progression. Nat Rev Cancer 2002; 2: 442-454.
21. Morel AP, Lièvre M, Thomas C, Hinkal G, Ansieau S, Puisieux A. Generation of breast cancer stem cells through epithelial-mesenchymal transition. PLoS ONE 2008; 3: e2888.
22. Santisteban M, Reiman JM, Asiedu MK, et al. Immune-induced epithelial to mesenchymal transition in vivo generates breast cancer stem cells. Cancer Res 2009; 69: 2887-2895.
23. Nicolini A, Ferrari P, Fini M, et al. Stem cells: their role in breast cancer development and resistance to treatment. Curr Pharm Biotechnol 2011; 12: 196-205.
24. Matsudaira P. Actin crosslinking proteins at the leading edge. Semin Cell Biol 1994; 5: 165-174.
25. Vignjevic D, Kojima S, Aratyn Y, Danciu O, Svitkina T, Borisy GG Role of fascin in filopodial protrusion. J Cell Biol 2006; 174: 863-875.
26. Hashimoto Y, Parsons M, Adams JC. Dual actin-bundling and protein kinase C-binding activities of fascin regulate carcinoma cell migration downstream of Rac and contribute to metastasis. Mol Biol Cell 2007; 18: 4591-4602.
27. Vignjevic D, Schoumacher M, Gavert N, et al. Fascin, a novel target of beta-catenin-TCF signaling, is expressed at the invasive front of human colon cancer. Cancer Res 2007; 67: 6844-6853.
28. Xie JJ, Xu LY, Wu JY, et al. Involvement of CYR61 and CTGF in the fascin-mediated proliferation and invasiveness of esophageal squamous cell carcinomas cells. Am J Pathol 2010; 176: 939-951.
29. Gavert N, Ben-Ze'ev A. Epithelial-mesenchymal transition and the invasive potential of tumors. Trends Mol Med 2008; 14: 199-209.
30. Wendt MK, Smith JA, Schiemann WP. Transforming growth factor-β-induced epithelial-mesenchymal transition facilitates epidermal growth factor-dependent breast cancer progression. Oncogene 2010; 29: 6485-6498.
31. Barcellos-Hoff MH, Akhurst RJ. Transforming growth factor-beta in breast cancer: too much, too late. Breast Cancer Res 2009; 11: 202.
32. Hermann PC, Huber SL, Herrler T, et al. Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer. Cell Stem Cell 2007; 1: 313-323.
33. Sullivan JP, Minna JD, Shay JW. Evidence for self-renewing lung cancer stem cells and their implications in tumor initiation, progression, and targeted therapy. Cancer Metastasis Rev 2010; 29: 61-72.
34. - breast cancer cells exhibit enhanced invasive properties: an early step necessary for metastasis. Breast Cancer Res 2006; 8: R59.